checkAd
    Startseite > Aktien > Ceapro > Nachrichten
    Ceapro Aktie
    0,2450
     
    CAD
    0,00 %
    0,0000 CAD
    Letzter Kurs 07.05.24 TSX Venture
    0,2450
     
    CAD
    41.000 STK
    Geldkurs 10:00:08
    0,2500
     
    CAD
    39.000 STK
    Briefkurs 10:00:08
    ISIN: CA1499071076 · WKN: 931278 · SYM: CZO · Kanada

    Neueste Nachrichten

    Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
    29.04.24 · globenewswire · Ceapro
    Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
    28.03.24 · globenewswire · Ceapro
    Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
    12.03.24 · globenewswire · Ceapro
    Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
    26.02.24 · globenewswire · Ceapro
    Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
    23.02.24 · globenewswire · Ceapro
    Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris
    15.02.24 · globenewswire · Ceapro
    Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights
    29.11.23 · globenewswire · Ceapro
    Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases
    27.11.23 · globenewswire · Ceapro
    Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology
    07.11.23 · globenewswire · Ceapro
    Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update
    29.08.23 · globenewswire · Ceapro
    Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise
    25.08.23 · globenewswire · Ceapro
    Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
    18.07.23 · globenewswire · Ceapro